# Arbovirus Testing Market > Arbovirus Testing Market Research Report By Test Type (Laboratory-Based Tests, Point-of-Care Tests), By Pathogen Detection (Vector-Based Testing, Human-Based Testing), By Technology (Serological Testing, Molecular Testing, Immunofluorescence), By Application (Diagnostic Testing, Surveillance, Research) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.75% - **2024:** $ 6.38 Billion - **2025:** $ 6.94 Billion - **2035:** $ 16.06 Billion - **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Bio-Rad Laboratories (US), Hologic (US), Cepheid (US), Becton Dickinson (US), GenMark Diagnostics (US) **Report ID:** MRFR/HC/38647-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/arbovirus-testing-market-40681 --- ## Market Summary ## **Arbovirus Testing Market Overview:** As per MRFR analysis, the Arbovirus Testing Market Size was estimated at 5.4 (USD Billion) in 2022. The Arbovirus Testing Market Industry is expected to grow from 5.87(USD Billion) in 2023 to 12.5 (USD Billion) by 2032. The Arbovirus Testing Market CAGR (growth rate) is expected to be around 8.75% during the forecast period (2024 - 2032). ### **Key Arbovirus Testing Market Trends Highlighted** The increasing incidence of arboviral diseases and improving diagnostic technologies are some of the key drivers in the market for arbovirus testing. Other opportunities are developing rapid and accurate point-of-care tests that can be used in remote and poorer regions of the world and exploring latest ideas such as nucleic acid testing and multiplex assays. Moreover, trends such as emergence of new arboviruses, more specific and sensitive tests, and increased application of molecular diagnostics are emerging. Such drivers, opportunities and trends can be used by manufacturers to explain how they are meeting the expectations of health care practitioners and patients and hence how they are enhancing the control and management of arboviral diseases. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Arbovirus Testing Market Drivers** ### **Rising Prevalence of Arboviral Infections** Arboviral infections are a major public health concern, with an estimated 200 million cases occurring worldwide each year. The most common arboviral infections include dengue, chikungunya, Zika, and yellow fever. These infections can cause a wide range of symptoms, from mild fever and rash to severe illness and death. The rising prevalence of arboviral infections is a major driver of the growth of the Global Arbovirus Testing Market Industry. As the number of cases of arboviral infections increases, so too does the demand for testing to diagnose and monitor these infections.This is driving the growth of the Global Arbovirus Testing Market Industry, as manufacturers and suppliers of arbovirus testing products and services seek to meet the growing demand for these products and services. ### **Increasing Awareness of Arboviral Infections** Another major driver of the growth of the Global Arbovirus Testing Market Industry is the increasing awareness of arboviral infections. In recent years, there has been a growing awareness of the risks associated with arboviral infections, as well as the importance of their early diagnosis and treatment. This is due in part to the increasing number of arboviral infections cases, as well as the growing availability of information regarding these infections.As a result, as consumers become more aware of the risks associated with arboviral infections, they become more likely to go through arbovirus testing, which helps in the driving of the growth of the Global Arbovirus Testing Market Industry. ### **Technological Advancements in Arbovirus Testing** Technological advancements in arbovirus testing are also driving the growth of the Global Arbovirus Testing Market Industry. In recent years, there have been several technological advancements in arbovirus testing, which have made it easier, faster, and more accurate to diagnose arboviral infections. These advancements include the development of new diagnostic tests, as well as the improvement of existing tests. As these technological advancements continue, they are expected to further drive the growth of the Global Arbovirus Testing Market Industry. ## **Arbovirus Testing Market Segment Insights:** ### **Arbovirus Testing Market Test Type Insights ** The Global Arbovirus Testing Market is divided into two major types, laboratory-based tests and point-of-care tests. The laboratory-based tests refer to diagnostic tests for arboviral infections, which are performed in a laboratory, requiring specialized equipment and trained personnel. The point-of-care tests, on the other hand, include all test methods that can be carried out either at the bedside of the patient or in a clinic, which are cheaper and easier to use.  While the superior accuracy and sensitivity of laboratory-based tests make them more popular, it is the point-of-care segment that is expected to grow more rapidly over the forecast period.In 2023, the laboratory-based tests segment is expected to generate 3.5 billion USD in revenue, which is higher than the 2.3 billion USD expected for the point-of-care segment. However, it will be the faster-growing segment over the forecast period, with a 2032 value of 7.2 billion USD for laboratory-based tests and 5.3 billion USD for point-of-care tests. The growth of the point-of-care tests segment is driven by several factors: the increase in arboviral infection rates, the growing demand for convenient and fast testing methods, and the popularity increase of point-of-care testing devices in general. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Arbovirus Testing Market Pathogen Detection Insights ** Based on pathogen detection, the global arbovirus testing market is categorized into two major segments: Vector-Based Testing and Human-Based Testing. The Vector-Based Testing segment held a substantial portion of the market revenue in 2023 and is likely to continue its dominance throughout the forecast period. This segment revolves around the analysis of mosquitoes or other vectors to detect arboviruses in them. Vector-based testing is largely fuelled by the rising incidence of vector-borne diseases and the need for effective surveillance and control measures.The Human-Based Testing segment is a type of testing that is employed to detect arboviruses in human samples such as blood or urine. This segment is poised to expand at an accelerated growth rate over the next years on account of the increasing knowledge and awareness about arboviral diseases and the availability of advanced diagnostic technologies. ### **Arbovirus Testing Market Technology Insights ** The Global Arbovirus Testing Market is segmented by technology into serological testing, molecular testing, and immunofluorescence. Serological testing is expected to dominate the market in 2023, accounting for over 40% of the market share. This is due to its low cost and ease of use. Molecular testing is expected to grow at the fastest CAGR during the forecast period, owing to its high sensitivity and specificity. Immunofluorescence is expected to account for a small share of the market in 2023, but is expected to grow at a moderate CAGR during the forecast period. ### **Arbovirus Testing Market Application Insights** The Global Arbovirus Testing Market is segmented based on application into diagnostic testing, surveillance, and research. Among these segments, diagnostic testing is expected to hold the largest share of the market in 2023, owing to the increasing prevalence of arboviral diseases worldwide. The demand for diagnostic testing kits is expected to grow significantly in the coming years, driven by factors such as the rising number of travelers visiting endemic areas, climate change, and the emergence of new arboviral strains. The surveillance segment is also expected to witness significant growth, as governments and public health organizations implement surveillance programs to track the spread of arboviral diseases and prevent outbreaks.The research segment is expected to grow at a moderate pace, driven by the need for continued research and development of new diagnostic tools and vaccines. ### **Arbovirus Testing Market Regional Insights ** The Global Arbovirus Testing Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023, owing to the high prevalence of arboviral diseases, such as Zika virus and West Nile virus, in the region. Europe is expected to be the second-largest market, followed by APAC, South America, and MEA. The APAC region is expected to witness the highest growth rate during the forecast period, owing to the increasing awareness of arboviral diseases and the rising demand for diagnostic tests in the region. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Arbovirus Testing Market Key Players and Competitive Insights:** Key players in the Arbovirus Testing Market are continuously developing innovative products to support the escalating demand for testing methods. Therefore, players in the market are investing in R activities to enhance the sensitivity, affordability, and specificity of the tests. Moreover, the Arbovirus Testing Market development is significantly influenced by strategic partnerships or collaborations among some of the key players as they aim to enhance their product range and establish a significant market presence.  Thus, in the next few years, the competitive environment in the market is expected to be highly responsive to the influx of new technologies and entrants.Leading companies, such as Roche, offer a wide range of tests for various arboviruses. For example, the Elecsys Zika Virus IgM test and Elecsys Dengue Virus IgM test provided by this company have high sensitivity and specificity. The Elecsys tests allow rapid testing and early detection of Zika and dengue viruses with limited cost. Furthermore, Roche is continuously developing new testing products, and the company has recently developed several new tests, including the cobas Zika and cobas Chikungunya tests. Also, Roche is currently developing tests that will be useful for detection of yellow fever, another emerging arbovirus.Abbott Laboratories also offer a wide array of rapid tests, including the Panbio Dengue Early Rapid Test, which detects the dengue virus in a matter of minutes. Abbott is currently focusing on the development of molecular methods for rapid and effective detection of a wide range of arboviruses and the development of multiplex testing. ### **Key Companies in the Arbovirus Testing Market Include:** ### **Arbovirus Testing Market Industry Developments** The Global Arbovirus Testing Market is projected to reach a valuation of USD 12.5 billion by 2032, expanding to a CAGR of 8.75% from 2024 to 2032. The market growth is attributed to the rising prevalence of arboviral diseases, increasing government initiatives for disease surveillance, and technological advancements in diagnostic methods. Asia-Pacific is expected to hold a significant market share due to the high incidence of arboviral diseases in the region. Key players in the market include Abbott Laboratories, bioMérieux, F. Hoffmann-La Roche, and Thermo Fisher Scientific. Recent developments include the approval of new diagnostic tests, such as the Arbovirus Multiplex RT-PCR Panel by the U.S. FDA, and the launch of rapid diagnostic tests for point-of-care settings.  ## **Arbovirus Testing Market Segmentation Insights** ### **Arbovirus Testing Market Test Type Outlook** ### **Arbovirus Testing Market Pathogen Detection Outlook** ### **Arbovirus Testing Market Technology Outlook** ### **Arbovirus Testing Market Application Outlook** ### **Arbovirus Testing Market Regional Outlook** ## Market Drivers ### Government Initiatives and Funding Government initiatives aimed at controlling arboviral diseases are significantly influencing the Arbovirus Testing Market. Many countries are allocating substantial funding for research and development of testing methods and public health campaigns. For example, initiatives to enhance vector control and surveillance programs are being implemented to reduce the transmission of arboviruses. This financial support not only fosters innovation in testing technologies but also encourages collaboration between public health agencies and private sector entities. As governments prioritize the establishment of robust testing frameworks, the Arbovirus Testing Market is likely to benefit from increased investments and resources dedicated to combating these infectious diseases. ### Rising Incidence of Arboviral Diseases The Arbovirus Testing Market is experiencing growth due to the rising incidence of arboviral diseases such as dengue, Zika, and chikungunya. These diseases have shown a concerning increase in prevalence, particularly in tropical and subtropical regions. For instance, the World Health Organization has reported a significant rise in dengue cases, with millions of infections annually. This surge necessitates effective testing solutions to manage outbreaks and ensure public health safety. Consequently, healthcare providers and governments are investing in advanced testing technologies to enhance disease surveillance and response strategies. The demand for accurate and rapid testing methods is likely to drive the Arbovirus Testing Market forward, as stakeholders seek to mitigate the impact of these diseases on populations. ### Advancements in Diagnostic Technologies Technological innovations are playing a pivotal role in shaping the Arbovirus Testing Market. The development of molecular diagnostic techniques, such as PCR and next-generation sequencing, has revolutionized the speed and accuracy of arbovirus detection. These advancements enable healthcare professionals to identify infections more rapidly, which is crucial during outbreaks. Moreover, the integration of point-of-care testing devices is enhancing accessibility to testing in remote areas. As a result, the market is witnessing an influx of new products that cater to diverse testing needs. The increasing adoption of these advanced diagnostic technologies is expected to propel the Arbovirus Testing Market, as they provide reliable solutions for timely disease management. ### Growing Demand for Preventive Healthcare The shift towards preventive healthcare is becoming increasingly evident within the Arbovirus Testing Market. As awareness of arboviral diseases rises, individuals and healthcare providers are emphasizing the importance of early detection and prevention strategies. This trend is leading to a higher demand for testing services, as proactive measures are recognized as essential in managing public health risks. Additionally, the integration of testing into routine health check-ups is gaining traction, further driving the market. The focus on preventive healthcare is expected to sustain the growth of the Arbovirus Testing Market, as stakeholders seek to implement comprehensive strategies to reduce the burden of arboviral diseases. ### Impact of Climate Change on Disease Patterns Climate change is emerging as a critical factor influencing the Arbovirus Testing Market. Alterations in temperature and precipitation patterns are expanding the habitats of mosquito vectors, thereby increasing the risk of arboviral disease transmission. Research indicates that regions previously unaffected by these diseases are now experiencing outbreaks, necessitating enhanced testing capabilities. As public health officials strive to adapt to these changing dynamics, the demand for effective arbovirus testing solutions is likely to rise. This evolving landscape underscores the importance of continuous monitoring and testing, positioning the Arbovirus Testing Market as a vital component in addressing the challenges posed by climate change on public health. ## Future Outlook The Arbovirus Testing Market is projected to grow at an 8.75% CAGR from 2025 to 2035, driven by technological advancements, increased awareness, and rising incidences of arboviral diseases. **New opportunities:** - Development of [rapid diagnostic kits](https://www.marketresearchfuture.com/reports/rapid-diagnostic-kit-market-43472) for remote areas Integration of AI for predictive analytics in testing Expansion of mobile testing units for community outreach By 2035, the market is expected to be robust, driven by innovation and increased demand. ## Segment Insights ### By Type: Laboratory-Based Tests (Largest) vs. Point-of-Care Tests (Fastest-Growing) The Arbovirus Testing Market is characterized by two primary types of testing: Laboratory-Based Tests and Point-of-Care Tests. Laboratory-Based Tests hold a significant share of the market, leveraging advanced technologies and thorough methodologies to ensure accurate results. These tests are preferred in clinical settings for their reliability, although they require more time and resources for processing. In contrast, Point-of-Care Tests have gained traction due to their convenience and rapid results, making them essential for urgent diagnoses in various healthcare settings. Testing Methods: Laboratory-Based Tests (Dominant) vs. Point-of-Care Tests (Emerging) Laboratory-Based Tests remain dominant within the Arbovirus Testing Market, known for their precision and comprehensive analysis, which is critical in arbovirus outbreaks management. These tests are typically conducted in specialized laboratories equipped with advanced tools, allowing for detailed evaluation of arbovirus infections. In contrast, Point-of-Care Tests are emerging rapidly, driven by the increasing demand for immediate results and ease of use. These tests are designed for quick diagnostics at the patient's location, enhancing screening and monitoring capabilities, particularly in remote areas. The shift towards Point-of-Care Tests reflects a broader trend towards more accessible healthcare solutions. ### By Pathogen Detection: Vector-Based Testing (Largest) vs. Human-Based Testing (Fastest-Growing) In the Arbovirus Testing Market, the distribution of market share between vector-based testing and human-based testing illustrates a significant trend. Vector-based testing currently holds the majority share, benefitting from the extensive reliance on mosquito vector data to assess arboviral prevalence. This segment's longstanding integration of established methodologies facilitates its dominance in the market, reflecting its vital role in outbreak preparedness and public health response. Conversely, the human-based testing segment is witnessing rapid growth, driven by increasing awareness of arboviral diseases and the need for quick, accurate diagnoses. This growth is spurred by advancements in molecular diagnostics, enhancing the ability to detect pathogens in human samples effectively. Moreover, the escalating incidence of diseases like Zika and dengue fever among human populations highlights the urgent need for these tests, thereby propelling the expansion of the human-based testing market. Testing Methodology: Vector-Based Testing (Dominant) vs. Human-Based Testing (Emerging) Vector-based testing remains a dominant methodology in the Arbovirus Testing Market, leveraged for its established protocols in detecting arboviruses through vector populations. This testing method utilizes various techniques, including serological assays and molecular diagnostics, which effectively identify viral presence in mosquitoes. In contrast, human-based testing is an emerging approach, increasingly vital due to rising incidences of arboviral infections in humans. This methodology focuses on directly identifying pathogens in human samples, offering rapid and reliable results. As public health initiatives grow to prioritize human health monitoring, the demand for human-based testing is accelerating, reflecting a shift towards more comprehensive arbovirus surveillance strategies that encompass both vectors and human populations. ### By Technology: Molecular Testing (Largest) vs. Serological Testing (Fastest-Growing) In the Arbovirus Testing Market, the segment distribution shows that Molecular Testing holds the largest market share, becoming the backbone of accurate and quick virus detection. This segment is favored for its sensitivity and specificity, contributing to its dominant position. [Serological Testing](https://www.marketresearchfuture.com/reports/serological-testing-market-43470), while currently having a smaller share, is rapidly gaining momentum due to the increasing demand for rapid and cost-effective testing solutions, especially in resource-limited settings. Technology: Molecular Testing (Dominant) vs. Serological Testing (Emerging) Molecular Testing has solidified its position as the dominant technology in the Arbovirus Testing Market due to its unparalleled ability to detect viral RNA, providing timely results that are crucial for patient management and outbreak control. The high accuracy of PCR techniques ensures that this segment remains favored among healthcare providers and laboratories. On the other hand, Serological Testing is emerging as a vital alternative, particularly as diagnostic methodologies evolve towards accessibility and quick outcomes. Its capacity to identify immune responses in patients presents significant advantages, especially in epidemiological studies. Together, these technologies enhance the overall diagnostic landscape for arboviruses. ### By Application: Diagnostic Testing (Largest) vs. Surveillance (Fastest-Growing) In the Arbovirus Testing Market, the Diagnostic Testing segment currently holds the largest share, demonstrating its critical role in identifying infections promptly. This segment has been strengthened by an increasing incidence of arboviral diseases, necessitating swift diagnostics for effective management and control. Conversely, Surveillance is gaining momentum due to heightened awareness of vector-borne diseases and the need for continuous monitoring and research, thus contributing to its rapid growth in market penetration. Diagnostic Testing (Dominant) vs. Surveillance (Emerging) The Diagnostic Testing segment has established itself as the dominant force in the Arbovirus Testing Market, primarily due to its direct application in managing and diagnosing diseases like dengue, Zika, and West Nile virus. This segment benefits from advancements in diagnostic technologies, allowing for faster and more accurate results. On the other hand, Surveillance represents an emerging focus area, increasingly important for public health initiatives. Coupled with technological improvements, enhanced data-sharing practices, and global collaborations, Surveillance is expected to expand its reach and influence in addressing arbovirus outbreaks across various regions. ## Regional Market Share Analysis The Global Arbovirus Testing Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023, owing to the high prevalence of arboviral diseases, such as Zika virus and West Nile virus, in the region. Europe is expected to be the second-largest market, followed by APAC, South America, and MEA. The APAC region is expected to witness the highest growth rate during the forecast period, owing to the increasing awareness of arboviral diseases and the rising demand for diagnostic tests in the region. ## Competitive Benchmarking Key players in the Arbovirus Testing Market are continuously developing innovative products to support the escalating demand for testing methods. Therefore, players in the market are investing in R activities to enhance the sensitivity, affordability, and specificity of the tests. Moreover, the Arbovirus Testing Market development is significantly influenced by strategic partnerships or collaborations among some of the key players as they aim to enhance their product range and establish a significant market presence. Thus, in the next few years, the competitive environment in the market is expected to be highly responsive to the influx of new technologies and entrants.Leading companies, such as Roche, offer a wide range of tests for various arboviruses. For example, the Elecsys Zika Virus IgM test and Elecsys Dengue Virus IgM test provided by this company have high sensitivity and specificity. The Elecsys tests allow rapid testing and early detection of Zika and dengue viruses with limited cost.Furthermore, Roche is continuously developing new testing products, and the company has recently developed several new tests, including the cobas Zika and cobas Chikungunya tests.Also, Roche is currently developing tests that will be useful for detection of yellow fever, another emerging arbovirus.Abbott Laboratories also offer a wide array of rapid tests, including the Panbio Dengue Early Rapid Test, which detects the dengue virus in a matter of minutes. Abbott is currently focusing on the development of molecular methods for rapid and effective detection of a wide range of arboviruses and the development of multiplex testing. ## Recent News & Developments The Global Arbovirus Testing Market is projected to reach a valuation of USD 12.5 billion by 2032, expanding to a CAGR of 8.75% from 2024 to 2032. The market growth is attributed to the rising prevalence of arboviral diseases, increasing government initiatives for disease surveillance, and technological advancements in diagnostic methods. Asia-Pacific is expected to hold a significant market share due to the high incidence of arboviral diseases in the region. Key players in the market include Abbott Laboratories, bioMérieux, F. Hoffmann-La Roche, and Thermo Fisher Scientific. Recent developments include the approval of new diagnostic tests, such as the Arbovirus Multiplex RT-PCR Panel by the U.S. FDA, and the launch of rapid diagnostic tests for point-of-care settings.  ## Report Scope | MARKET SIZE 2024 | 6.384(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 6.942(USD Billion) | | MARKET SIZE 2035 | 16.06(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.75% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Bio-Rad Laboratories (US), Hologic (US), Cepheid (US), Becton Dickinson (US), GenMark Diagnostics (US) | | Segments Covered | Test Type, Pathogen Detection, Technology, Application, Regional | | Key Market Opportunities | Advancements in molecular diagnostics enhance accuracy and speed in the Arbovirus Testing Market. | | Key Market Dynamics | Rising demand for rapid diagnostic tests drives innovation and competition in the Arbovirus Testing Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Arbovirus Testing Market by 2035?** A: The Arbovirus Testing Market is projected to reach a valuation of 16.06 USD Billion by 2035. **Q: What was the market valuation of the Arbovirus Testing Market in 2024?** A: In 2024, the Arbovirus Testing Market was valued at 6.384 USD Billion. **Q: What is the expected CAGR for the Arbovirus Testing Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Arbovirus Testing Market during the forecast period 2025 - 2035 is 8.75%. **Q: Which companies are considered key players in the Arbovirus Testing Market?** A: Key players in the Arbovirus Testing Market include Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific. **Q: What are the main segments of the Arbovirus Testing Market?** A: The main segments of the Arbovirus Testing Market include Type, Pathogen Detection, Technology, and Application. **Q: How much is the Laboratory-Based Tests segment projected to grow by 2035?** A: The Laboratory-Based Tests segment is projected to grow from 3.5 USD Billion in 2024 to 8.5 USD Billion by 2035. **Q: What is the projected growth for Human-Based Testing in the Pathogen Detection segment?** A: Human-Based Testing in the Pathogen Detection segment is expected to increase from 3.884 USD Billion in 2024 to 10.56 USD Billion by 2035. **Q: What are the expected values for Molecular Testing by 2035?** A: Molecular Testing is projected to grow from 2.5 USD Billion in 2024 to 6.5 USD Billion by 2035. **Q: What is the anticipated growth for the Surveillance application in the Arbovirus Testing Market?** A: The Surveillance application is expected to grow from 2.0 USD Billion in 2024 to 5.0 USD Billion by 2035. **Q: How does the Point-of-Care Tests segment compare to Laboratory-Based Tests in terms of growth?** A: The Point-of-Care Tests segment is projected to grow from 2.884 USD Billion in 2024 to 7.56 USD Billion by 2035, indicating robust growth compared to Laboratory-Based Tests. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/arbovirus-testing-market-40681*